1. Home
  2. UL vs BMY Comparison

UL vs BMY Comparison

Compare UL & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unilever PLC

UL

Unilever PLC

N/A

Current Price

$61.65

Market Cap

132.9B

ML Signal

N/A

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

N/A

Current Price

$63.94

Market Cap

113.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UL
BMY
Founded
1930
1887
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.9B
113.5B
IPO Year
1999
2006

Fundamental Metrics

Financial Performance
Metric
UL
BMY
Price
$61.65
$63.94
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
$61.73
AVG Volume (30 Days)
3.6M
7.3M
Earning Date
03-12-2026
04-30-2026
Dividend Yield
4.04%
4.38%
EPS Growth
N/A
178.46
EPS
N/A
2.93
Revenue
N/A
$48,194,000,000.00
Revenue This Year
$2.53
N/A
Revenue Next Year
$3.78
N/A
P/E Ratio
$14.29
$21.98
Revenue Growth
N/A
N/A
52 Week Low
$54.75
$42.52
52 Week High
$74.98
$68.64

Technical Indicators

Market Signals
Indicator
UL
BMY
Relative Strength Index (RSI) 39.17 43.44
Support Level $61.38 $63.00
Resistance Level $63.61 $68.37
Average True Range (ATR) 0.78 1.27
MACD -0.34 -0.56
Stochastic Oscillator 0.50 4.47

Price Performance

Historical Comparison
UL
BMY

About UL Unilever PLC

Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: